# Rivopharm S.A. – FDA Inspection, Jan 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/rivopharm-sa/6be8540d-455e-43b7-b5df-0663469a646c
Source feed: FDA_Inspections

> FDA inspection 1078356 of Rivopharm S.A., January 18, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1078356
- Company Name: Rivopharm S.A.
- Inspection Date: 2019-01-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1264905 - 2023-06-23
- [FDA Inspection 948852 - 2015-10-30](https://www.keypedia.com/records/fda_inspections/rivopharm-sa/1db04c02-d7c7-4b36-957e-643d5aad923d)
- FDA Inspection 873626 - 2014-04-03

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)

Company: https://www.keypedia.com/companies/rivopharm-sa/7cc8f5f7-352e-451c-bd6f-5abaec132ce0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c